Cal Warriner of the Mass Torts Unit of Searcy Denney will be speaking this week at the Plaintiff Forum on Pharmaceutical Litigation: Transvaginal Mesh, Actos and Orthopedic Devices. The conference will be held on Friday of this week (October 5, 2012) at Le Méridien in Philadelphia, Pennsylvania. Cal will be […]
Category: Mass Torts
With all of the bad news coming out about the dangers of defective synthetic transvaginal mesh made of polypropylene used to treat prolapse and incontinence as well as the thousands of lawsuits waiting to be heard in state and federal courts filed by severely injured women looking to regain their […]
There is no doubt that we at Searcy Denney are seeing more and more cases of bone fractures that are occurring among women taking bisphosphonates to treat osteoporosis and osteopenia. But there may be even more cases out there that are going unreported. The authors of this article, William Ward […]
Women are increasingly deciding that their transvaginal mesh implant is causing more complications than it cured and are opting to have it removed, but a new report says the removal procedure may cause a host of injuries to the uterus. Researchers from the Mayo Clinic and Spectrum Health Medical Group […]
Last January 3, the U.S. Food and Drug Administration (FDA) decided to get tough on transvaginal mesh manufacturers. After noting a five-fold increase in complications among women implanted with the polypropylene mesh to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), the FDA asked the mesh makers to […]
You have to give it to Shirley Boles, 74 – she just doesn’t give up. Today concluded the third in a series of trials against drug giant, Merck, over the osteoporosis drug, Fosamax. Boles of Walton Beach, Florida, took the drug for nine years and developed jaw necrosis. On Tuesday, […]
In a white paper about hernia mesh, analyst Winifred S. Hayes of Hayes Consulting helps one client figure out how to save money and be more efficient with their mesh purchases. The problem has been that in the case of hernia mesh, hospitals buy from a number of vendors and […]
A new Danish study in the journal, Calcified Tissue International, finds that a lower dose of osteoporosis drugs, also known as bisphosphonates, may actually represent a greater risk by about 50 percent of acute myocardial infarction, or clogging of the coronary vessels, when compared to a higher dose. Researchers from […]
Too often it seems that white collar crime pays. That may not be the case for executives of Johnson & Johnson in a couple of high-profile cases moving toward trial. Not only will Ethicon (a division of J & J) be forced to be deposed in the ongoing transvaginal mesh […]
The consumer advocacy group, Public Citizen, has filed a federal complaint against the U.S. Food and Drug Administration (FDA) to have the higher dose of the Alzheimer’s drug, Aricept, taken off the market because of the risk of fatal complications. The group made the first request 15 months ago and […]
